Navigation Links
Alexandria Real Estate Equities, Inc. Provides Update
Date:10/29/2009

ip and commitment to efficient practices," said Vincent Ciruzzi, Senior Vice President, Construction and Development, Alexandria Real Estate Equities, Inc.

Alexandria Real Estate Equities, Inc., Landlord of Choice to the Life Science Industry®, is the largest owner and preeminent first-in-class real estate investment trust focused principally on science-driven cluster formation. Alexandria is the leading provider of high-quality environmentally sustainable real estate, technical infrastructure and services to the broad and diverse life science industry. Client tenants include institutional (universities and independent not-for-profit institutions), pharmaceutical, biopharmaceutical, medical device, product, service, and translational entities, as well as government agencies. Alexandria's operating platform is based on the principle of "clustering", with assets and operations located in key life science markets.

This press release contains forward-looking statements, including earnings guidance, within the meaning of the federal securities laws. Actual results may differ materially from those projected in the forward-looking statements. Additional information concerning factors that could cause actual results to differ materially from those in the forward-looking statements is contained in our Annual Report on Form 10-K and our other periodic reports filed with the Securities and Exchange Commission.

SOURCE Alexandria Real Estate Equities, Inc.


'/>"/>
SOURCE Alexandria Real Estate Equities, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Alexandria Real Estate Equities, Inc. Reports Third Quarter 2007 Results
2. Alexandria Real Estate Equities, Inc. Features Green Buildings and Sustainable Operations Initiatives and Tour at 2008 BIO
3. Alexandria Real Estate Equities, Inc. Announces Pricing of Public Follow-On Offering of 7,000,000 Shares of Common Stock
4. Alexandria Real Estate Equities, Inc. Signs Biopharmaceutical Company, Lilly, as Anchor New York City Tenant at the Alexandria Center for Science and Technology
5. Alexandria Real Estate Equities, Inc. Announces Public Follow-on Offering of 3,000,000 Shares of Common Stock
6. Coherent Announces Restatement Related to Stock-Based Compensation
7. Symmetry Medical Discloses Accounting Issues at Sheffield, UK Operating Unit and Possible Restatement
8. Angiotech announces filing of audited financial results for the year ended December 31, 2007 and restatement of results for the year ended December 31, 2006
9. Unigene Restates Policy on Analyst Reports
10. Rosetta Genomics Announces Expansion of its MicroRNA Intellectual Property Estate
11. Environmental Power Holds Ground Breaking Ceremony for Renewable Natural Gas Facility at Rio Leche Estates

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/19/2009)..., SEATTLE, Nov. 19 Omero...udited financial results for the third quarter end...September 30, 2009, Omeros reported a net loss of ... net loss of $7.4 million, or $2.54 per share, for...d September 30, 2009, the Company reported a net l...
(Date:11/19/2009)... , MALVERN, Pa. and WALTHAM, Mass., Nov. 19 /PR... Decision Resources find that the leading driver o...Europe is broad-spectrum activity against gram-pos...ety of organisms that can cause nosocomial pneumon...look primarily for agents that provide appropriate...
(Date:11/19/2009)... InSound is honored by latest awar... Newark, CA (PRWEB) November 16, 2009 -- ...o;invisible” hearing aid from InSound Medica... Award in the Health category.   &n...signed to reside deep in the hearing canal for up ...
(Date:11/18/2009)...AIGN, Ill. Imagine a polka-dotted postage stamp t... simply by changing colors. , As reported in the... Kenneth Suslick and his team at the University of...e general detection of toxic industrial chemicals ...orks by visualizing odors. This sensor array coul...
Breaking Biology Technology:Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 2Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 3Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 4Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 5Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 6Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 7Omeros Corporation Reports Third Quarter 2009 Financial Results and Development Highlights 8Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 2Broad-Spectrum Antibacterial Activity is the Most Important Driver of Antibiotic Selection for Nosocomial Pneumonia In Europe 3Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 2Popular Science Awards Lyric “Invisible” Hearing Aid 2009 “Best of What's New” Award 3Opto-electronic nose sniffs out toxic gases 2Opto-electronic nose sniffs out toxic gases 3
...LO ALTO, Calif., Nov. 20 Varian, Inc.,(NasdaqGS: ...ident and CEO,will speak at the Nasdaq OMX 22nd In...008 at 9:45 a.m. Eastern time. , A live webc... from Varian,Inc.,s Web site at http://www.varian...ick on "Investors." An archived replay will be av...
...INCETON, N.J., Nov. 20 Laureate Pharma, Inc., a,f...ein production company,today announced that it has...the Year" by The Eastern Technology Council, the l...ion in the greater Philadelphia, PA region. The,c... achievement of milestones,and strength of its man...
... Histogen, Inc., a regener...on the products of newborn fibroblasts, today anno...cal evaluation of ReGenica for hair regrowth. ReGe...ve formulation of wnt proteins and natural cofacto...ew hair follicles. , San ...
Other Biology Technology:Laureate Pharma Honored as Emerging Life Sciences Company of the Year 2Histogen Announces Start of Hair Regrowth Clinical Evaluation 2
(Date:11/22/2009)...ntists have inventoried an astonishing abundance, ...t have never known sunlight - creatures that someh... 5,000 meters (~3 miles) below the ocean waves. ,...r vanguard technologies, animals known to thrive i...diverse collection of species ranging from crabs t...
(Date:11/22/2009)..., 2009 Agios Pharmaceuticals today announced that...me, that the mutated IDH1 gene has a novel enzyme ... oncogene. This breakthrough discovery shows that ...hydroxyglutarate (2HG), which may contribute to th...the most common type of brain cancers. This discov...
(Date:11/20/2009)...rk on many scientific and technological frontiers....ided support that totals nearly $4.3 million for t...under the American Recovery and Reinvestment Act o...rants for investigation of solar phenomena. Philip...l enhance the capabilities of NJIT,s Big Bear Sola...
Breaking Biology News(10 mins):Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 2Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 3Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 4Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 5Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 6Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 7Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 8Beyond sunlight: Explorers census 17,650 ocean species between edge of darkness and black abyss 9Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer 2Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer 3Cancer metabolism discovery uncovers new role of IDH1 gene mutation in brain cancer 4NJIT receives NSF funding to improve Big Bear Telescope, study solar energy 2Cardiogenesis Reports Second Quarter 2009 Results 54487 1Cardiogenesis Reports Second Quarter 2009 Results 54487 2Cardiogenesis Reports Second Quarter 2009 Results 54487 3Cardiogenesis Reports Second Quarter 2009 Results 54487 4Cardiogenesis Reports Second Quarter 2009 Results 54487 5Cardiogenesis Reports Second Quarter 2009 Results 54487 6Cardiogenesis Reports Second Quarter 2009 Results 54487 7ClearWay Minnesota 28SM 29 Adds New Director of Research 54486 1Treat Mind Body in RA Patients 3A Study 54482 1Treat Mind Body in RA Patients 3A Study 54482 2
...dies of the birth and incorporation of neurons int...dult neurogenesispromise intriguing insights into ...he causes of depression and other psychiatric diso...ory Press ( www.cshlpress.com ) helps to define th... ( http://www.cshlpress.com/link/adultneuro.htm ) ...
... of world-leading scientists including those who ...rown at a parasitic worm less than 1mm long. , T...attacks potato crops all over the world and is par...e the potato is a subsistence crop. A 1.7 million ...quence its DNA, hopes to shed light on the mechani...
...ree of Life for flowering plants has been revealed...hese plants to date, report scientists from The Un...ida. , The scientists, publishing two papers in P...s week online, found that the two largest groups o...latives) and eudicots (including sunflowers and to...
Other Biology News:New book defines promising young field of adult neurogenesis 2New research to decode the genetic secrets of prolific potato pest 2Tree of life for flowering plants reveals relationships among major groups 2
BD BioCoat Poly-D-Lysine 35 mm Culture Dishes from BD Biosciences - Discovery Labware
BD BioCoat Laminin 35 mm Culture Dishes from BD Biosciences - Discovery Labware
BD BioCoat Collagen I 35 mm Culture Dishes from BD Biosciences - Discovery Labware
Corning C ulture Dishes, 150X25 mm, Tc-Treated, PS, Sterile from Sigma-Aldrich
Biology Products: